Patrick Y. Wen, MD
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Patrick Y. Wen, MD sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Patrick Y. Wen, MD: 7 sponsored US clinical trials, none currently recruiting.
Patrick Y. Wen, MD sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Meningioma, with 1 trials.
Upper-quartile sponsor footprint
Patrick Y. Wen, MD sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
BIBF 1120 for Recurrent High-Grade Gliomas
NCT01380782
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
NCT01339039
Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
NCT01339052
Monthly SOM230C for Recurrent or Progressive Meningioma
NCT00859040
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
NCT00859222
Dose-Intense Temozolomide in Recurrent Glioblastoma
NCT00657267
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
NCT00441142
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
Therapeutic Areas
How the Patrick Y. Wen, MD early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 6 completed (86%).
Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Meningioma (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Patrick Y. Wen, MD: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Patrick Y. Wen, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Patrick Y. Wen, MD page
7 registered trials is a research-attention snapshot, not an endorsement of Patrick Y. Wen, MD or any single study.
- None of Patrick Y. Wen, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Meningioma is the condition Patrick Y. Wen, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Meningioma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Patrick Y. Wen, MD pipeline card: 7 registered trials from official public datasets.Report a data error.